Terumo Co. (OTCMKTS:TRUMY) Short Interest Update

Terumo Co. (OTCMKTS:TRUMY) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 30,200 shares, a decrease of 44.5% from the April 30th total of 54,400 shares. Based on an average trading volume of 180,600 shares, the short-interest ratio is currently 0.2 days. Currently, 0.0% of the company’s stock are sold short.

Terumo Stock Up 0.2%

TRUMY stock opened at $18.77 on Friday. Terumo has a fifty-two week low of $14.06 and a fifty-two week high of $21.22. The business’s 50 day moving average price is $18.89 and its two-hundred day moving average price is $19.00. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94. The company has a market capitalization of $27.79 billion, a price-to-earnings ratio of 36.10 and a beta of 0.88.

Terumo (OTCMKTS:TRUMY) last posted its earnings results on Wednesday, May 14th. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.07). The business had revenue of $1.79 billion during the quarter, compared to analysts’ expectations of $1.79 billion.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.